Amphastar  Nanjing

  • Ongoing Projects

             At present, ANP has more than 20 R&D projects, ranging from biotechnology, chemical synthesis, peptide synthesis and biological extraction to other fields of          APIs and drug products.

  • Patents

           By the end of 2016 year, a total of 24 patent applications had been submitted and approved. Another 7 Chinese invention patent applications and 4 overseas patent applications have been submitted.

  • Registration Approval

           By the end of 2016 year, ANP had submitted 8 DMF to FDA. In 2017 ANP is planning to file registration application to CFDA and EU EMA.